791
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A population-level post-screening treatment cost framework to help inform vision screening choices for children under the age of seven

, PhD, , PhD, , PhD, , MD, PhD, , PhDORCID Icon, , PhD & , PhD show all

References

  • Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: WHO; 1968.
  • Lowry EA, De Alba Campomanes AG. Cost-effectiveness of school-based eye examinations in preschoolers referred for follow-up from visual screening. JAMA Ophthalmol. 2016;134(6):658–664. doi:10.1001/jamaophthalmol.2016.0619.
  • Membreno JH, Brown MM, Brown GC, Sharma S, Beauchamp GR. A cost-utility analysis of therapy for amblyopia. Ophthalmology. 2002;109(12):2265–2271. doi:10.1016/S0161-6420(02)01286-1.
  • Heijnsdijk EAM, Verkleij ML, Carlton J, et al. The cost-effectiveness of different visual acuity screening strategies in three European countries: a microsimulation study. Prev Med Rep. 2022;28:101868. doi:10.1016/j.pmedr.2022.101868.
  • Evans JR, Lawrenson JG, Ramke J, et al. Identification and critical appraisal of evidence for interventions for refractive error to support the development of the WHO package of eye care interventions: a systematic review of clinical practice guidelines. Ophthalmic Physiol Opt. 2022;42(3):526–533. doi:10.1111/opo.12963.
  • Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation. Health Technol Assess. 2008;12(25):iii, xi–194. doi:10.3310/hta12250.
  • Carlton J, Griffiths HJ, Mazzone P, Horwood AM, Sloot F, Study Consortium E. A comprehensive overview of vision screening programmes across 46 countries. Br Ir Orthopt J. 2022;18(1):27–47. doi:10.22599/bioj.260.
  • Stiff H, Dimenstein N, Larson SA. Vision screening outcomes in children less than 3 years of age compared with children 3 years and older. J Aapos. 2020;24(5):e293.1–.e.4. doi:10.1016/j.jaapos.2020.05.016.
  • Konig HH, Barry JC. Economic evaluation of different methods of screening for amblyopia in kindergarten. Pediatrics. 2002;109(4):e59. doi:10.1542/peds.109.4.e59.
  • Rein DB, Wittenborn JS, Zhang X, Song M, Saaddine JB, Vision Cost-Effectiveness S. The potential cost-effectiveness of amblyopia screening programs. J Pediatr Ophthalmol Strabismus. 2012;49(3):146–155. doi:10.3928/01913913-20110823-02.
  • Van der Ploeg CPB, Grevinga M, Eekhout I, et al. Costs and effects of conventional vision screening and photoscreening in the Dutch preventive child health care system. Eur J Public Health. 2020;31(1):7–12. doi:10.1093/eurpub/ckaa098.
  • UK National Screening Committee. UK NSC recommendation on vision defects screening in children. London: Public Health England. https://legacyscreening.phe.org.uk/vision-child. Published 2013. Accessed July 3, 2023.
  • Griffiths H, Carlton J, Mazzone P. BIOS screening audit report 2015–2016. British and Irish Orthoptic Society. https://figshare.shef.ac.uk/articles/BIOS_Screening_Audit_report_2016-2017/6839813/1. Published 2017. Accessed January 15, 2019.
  • Griffiths H, Carlton J, Mazzone P. BIOS screening audit report 2016–2017. British and Irish Orthoptic Society. https://figshare.com/articles/BIOS_Screening_Audit_report_2015-2016/5532910. Published 2018. Accessed January 15, 2019.
  • Miller J, Dobson V, Harvey E, Sherrill D. Cost-efficient vision screening for astigmatism in native American preschool children. Invest Ophthalmol Vis Sci. 2003;44(9):3756–3763. doi:10.1167/iovs.02-0970.
  • Lowry EA, De Alba Campomanes AG. Efficient referral thresholds in autorefraction-based preschool screening. Am J Ophthalmol. 2015;159(6):1180–1187. doi:10.1016/j.ajo.2015.02.012.
  • Asare AO, Wong AMF, Maurer D, Kulandaivelu Y, Saunders N, Ungar WJ. Economic evaluations of vision screening to detect amblyopia and refractive errors in children: a systematic review. Can J Public Health. 2022;113(2):297–311. doi:10.17269/s41997-021-00572-x.
  • Horwood AM, Griffiths HJ, Carlton J, et al. Scope and costs of autorefraction and photoscreening for childhood amblyopia—a systematic narrative review in relation to the EUSCREEN project data. Eye. 2020;35(3):739–752. doi:10.1038/s41433-020-01261-8.
  • Leman R, Clausen MM, Bates J, Stark L, Arnold KK, Arnold RW. A comparison of patched HOTV visual acuity and photoscreening. J Sch Nurs. 2006;22(4):237–243. doi:10.1177/10598405050220040901.
  • EUSCREEN Foundation. Cost-effectiveness model 2021. https://www.euscreen.org/cost-effectiveness-model/. Accessed July 3, 2023.
  • Kik J, Heijnsdijk EAM, Mackey AR, et al. Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes. J Med Screen. 2022;30(2):1–7. doi:10.1177/09691413221126677.
  • Arnold RW, Armitage D, Gionet EG, et al. The cost and yield of photoscreening: impact of photoscreening on overall pediatric ophthalmic costs. J Pediatric Ophthalmol Strabismus. 2005;42(2):103–111. doi:10.3928/01913913-20050301-05.
  • Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschitz N, Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J Aapos. 2000;4(4):194–199. doi:10.1067/mpa.2000.105274.
  • Systematic review of the scope and cost-effectiveness of the use of photoscreening as a test for childhood vision impairment PROSPERO 2018 CRD42018110283. 2020. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018110283. Accessed January 10, 2023.
  • Horwood A, Lysons D, Sandford D, Richardson G. Costs and effectiveness of two models of school-entry visual acuity screening in the UK. Strabismus. 2021;29(3):174–181. doi:10.1080/09273972.2021.1948074.
  • Pentland L, Patel S. Scottish pre-school vision screening – first 3 years of National data. Br Ir Orthopt J. 2020;16(1):13–18. doi:10.22599/bioj.138.
  • Oliveira I, Ferreira A, Vieira R, et al. The impact of early photoscreening on medium-term visual acuity: a population-based study. J Pediatr Ophthalmol Strabismus. 2022;60(3):178–183. doi:10.3928/01913913-20220428-02.
  • Leone JF, Mitchell P, Kifley A, Rose KA, Sydney Childhood Eye S. Normative visual acuity in infants and preschool-aged children in Sydney. Acta Ophthalmol. 2014;92(7):e521–9. doi:10.1111/aos.12366.
  • Stewart C, Moseley M, Fielder A, Stephens D, MOTAScooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Brit J Ophthalmol. 2004;88(12):1541–1542. doi:10.1136/bjo.2004.044214.
  • Clarke MP. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ. 2003;327(7426):1251–0. doi:10.1136/bmj.327.7426.1251.
  • Greenwood JA, Tailor VK, Sloper JJ, Simmers AJ, Bex PJ, Dakin SC. Visual acuity, crowding, and stereo-vision are linked in children with and without amblyopia. Invest Ophthalmol Vis Sci. 2012;53(12):7655–7665. doi:10.1167/iovs.12-10313.
  • Holmes JM, Beck RW, Kraker RT, et al. Risk of amblyopia recurrence after cessation of treatment. J Aapos. 2004;8(5):420–428.
  • Moghaddam AA, Kargozar A, Zarei-Ghanavati M, Najjaran M, Nozari V, Shakeri MT. Screening for amblyopia risk factors in pre-verbal children using the Plusoptix photoscreener: a cross-sectional population-based study. Br J Ophthalmol. 2012;96(1):83–86. doi:10.1136/bjo.2010.190405.
  • Longmuir SQ, Boese EA, Pfeifer W, Zimmerman B, Short L, Scott WE. Practical community photoscreening in very young children. Pediatrics. 2013;131(3):e764–e9. doi:10.1542/peds.2012-1638.
  • Farbrother JE. Spectacle prescribing in childhood: a survey of hospital optometrists. Br J Ophthalmol. 2008;92(3):392–395. doi:10.1136/bjo.2007.123497.
  • Pfeifer WL, Scott WE, Longmuir SQ. Comparison of prescribing patterns of ophthalmologists and optometrists to published guidelines. J Aapos. 2014;18(4):e35–e6. doi:10.1016/j.jaapos.2014.07.115.
  • Leat S. To prescribe or not to prescribe? Guidelines for spectacle prescribing in infants and children. Clin Exp Optometry. 2011;94(6):514–527. doi:10.1111/j.1444-0938.2011.00600.x.
  • Lowry EA, Lui R, Enanoria W, Keenan J, De Alba Campomanes AG. Repeat retinomax screening changes positive predictive value. J Aapos. 2014;18(1):45–49. doi:10.1016/j.jaapos.2013.11.004.
  • Goodman L, Chakraborty A, Paudel N, et al. Vision screening at two years does not reduce the prevalence of reduced vision at four and a half years of age. Clin Exp Optometry. 2018;101(4):527–534. doi:10.1111/cxo.12645.
  • White E, Walsh L. The impact of occlusion therapy and predictors on amblyopia dose–response relationship. Strabismus. 2022;30(2):78–89. doi:10.1080/09273972.2022.2046114.
  • Repka MX, Kraker RT, Holmes JM, et al. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial. JAMA Ophthalmol. 2014;132(7):799–805. doi:10.1001/jamaophthalmol.2014.392.
  • Holmes JM, Lazar EL, Melia BM, et al. Effect of age on response to amblyopia treatment in children. Arch Ophthalmol. 2011;129(11):1451–1457. doi:10.1001/archophthalmol.2011.179.
  • Holmes JM, Lazar E, Melia M, Pediatric Eye Disease Investigator G. Response to amblyopia therapy depends on child’s age. Invest Ophthalmol Vis Sci. 2010;51:4757.
  • Wallace DK, Chandler DL, Beck RW, et al. Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol. 2007;144(4):487–496. doi:10.1016/j.ajo.2007.05.040.
  • Stewart C, Moseley M, Fielder A, Fielder AR, Stephens D, Cooperative M. Treatment dose-response relationship for occlusion therapy for the treatment of amblyopia: results from the MOTAS study. Invest Ophthalmol Vis Sci. 2004;45(9):3048–3054. doi:10.1167/iovs.04-0250.
  • Donahue SP. The relationship between anisometropia, patient age, and the development of amblyopia. Trans Am Ophthalmol Soc. 2005;103:313–336.
  • Williams C, Northstone K, Harrad R, Sparrow J, Harvey I. Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study. Br J Ophthalmol. 2003;87(8):988–993. doi:10.1136/bjo.87.8.988.
  • Hunter D, Cotter S. Early diagnosis of amblyopia. Vis Neurosci. 2018;35:E013. doi:10.1017/S0952523817000207.
  • Solebo AL, Cumberland PM, Rahi JS. Whole-population vision screening in children aged 4-5 years to detect amblyopia. Lancet. 2015;385(9984):2308–2319. doi:10.1016/S0140-6736(14)60522-5.
  • Clarke M. Review of amblyopia treatment: are we overtreating children with amblyopia. Brit & Irish Orthoptic J. 2010;7:3–7. doi:10.22599/bioj.17.
  • Arnold RW, Donahue SP, Silbert DI, et al. AAPOS uniform guidelines for instrument-based pediatric vision screen validation 2021. JAAPOS. 2022;26(1):E1–E6. doi:10.1016/j.jaapos.2021.09.009.
  • Dahlmann-Noor AH, Vrotsou K, Kostakis V, et al. Vision screening in children by Plusoptix vision screener compared with gold-standard orthoptic assessment. Br J Ophthalmol. 2009;93(3):342–345. doi:10.1136/bjo.2008.138115.
  • Kemper AR, Clark SJ. Preschool vision screening by family physicians. J Pediatric Ophthalmol Strabismus. 2007;44(1):24–27. doi:10.3928/01913913-20070101-02.
  • Donahue SP, Baker JD, Scott WE, et al. Lions clubs international foundation core four photoscreening: results from 17 programs and 400,000 preschool children. JAAPOS. 2006;10(1):44–48. doi:10.1016/j.jaapos.2005.08.007.
  • Sloot F, Sami A, Karaman H, et al. Effect of omission of population-based eye screening at age 6–9 months in the Netherlands. Acta Ophthalmol. 2014;93(4):318–321. doi:10.1111/aos.12556.
  • Carlton J, Griffiths H, Horwood A, Mazzone P, Walker R, Simonsz H. Acceptability of childhood screening: a systematic narrative review. Public Health. 2021;193:126–138. doi:10.1016/j.puhe.2021.02.005.
  • Kik J, Nordmann M, Cainap S, et al. Implementation of paediatric vision screening in urban and rural areas in Cluj county, Romania. Int J Equity Health. 2021;20(1):256. doi:10.1186/s12939-021-01564-6.
  • Longmuir SQ, Pfeifer W, Leon A, Olson RJ, Short L, Scott WE. Nine-year results of a volunteer lay network photoscreening program of 147 809 children using a photoscreener in Iowa. Ophthalmology. 2010;117(10):1869–1875. doi:10.1016/j.ophtha.2010.03.036.
  • Hendler K, Mehravaran S, Lu X, Brown SI, Mondino BJ, Coleman AL. Refractive errors and amblyopia in the UCLA preschool vision program; First Year results. Am J Ophthalmol. 2016;172:80–86. doi:10.1016/j.ajo.2016.09.010.
  • Darusman K. Amblyopia risk factors findings in preschool children in Jakarta, Indonesia using the Plusoptix pediatric autorefractor A09. Int Eye Sci. 2014;14:2119–2121.
  • Arnold RW, Armitage MD, Gionet EG, et al. The cost and yield of photoscreening: impact of photoscreening on overall pediatric ophthalmic costs. J Pediatr Ophthalmol Strabismus. 2005;42(2):103–111. doi:10.3928/01913913-20050301-05.
  • Sloot F, Sami A, Karaman H, et al. Semistructured observation of population-based eye screening in the Netherlands. Strabismus. 2017;25(4):1–8. doi:10.1080/09273972.2017.1395596.
  • Donahue SP, Arthur B, Neely DE, Arnold RW, Silbert D, Ruben JB. Guidelines for automated preschool vision screening: a 10-year, evidence-based update. J Aapos. 2013;17(1):4–8. doi:10.1016/j.jaapos.2012.09.012.
  • Clarke N, Shacks J, Kerr ARE, Bottrell CL, Poulsen MK, Yin L. Use of a noncycloplegic autorefractor to perform vision screening in preschools. J Sch Nurs. 2008;24(3):158–163. doi:10.1177/1059840544556677.
  • Hutchinson A, Morse CL, Hercinovic A, et al. AAO PPP pediatric ophthalmology/strabismus panel. Pediatric eye evaluations PPP – 2022. American Academy of Ophthalmology. https://www.aao.org/education/preferred-practice-pattern/pediatric-eye-evaluations-ppp-2022. Published 2022. Accessed July 3, 2023.
  • Tarczy-Hornoch K. Wait, what are we screening for again? J Aapos. 2022;26(2):55–57. doi:10.1016/j.jaapos.2022.03.002.
  • Ciner EB, Kulp MT, Pistilli M, et al. Associations between visual function and magnitude of refractive error for emmetropic to moderately hyperopic 4- and 5-year-old children in the vision in preschoolers - hyperopia in preschoolers study. Ophthalmic Physiol Opt. 2021;41(3):553–564. doi:10.1111/opo.12810.
  • Chung I, Kulp M, Mitchell G, et al. A randomized clinical trial of Short-term effects of glasses correction for low to moderate hyperopia in children: a pilot study. Vision Dev Rehabil. 2021;7(3):177–194.
  • Bruinenberg A, Nordmann M, Asjes-Tydeman WL, et al. Preparation of the early glasses study: a randomized, controlled trial investigating the effect of early glasses for high refractive error on the development of amblyopia. Invest Ophthalmol Vis Sci. 2021;62(8):145–.
  • Kumaran SE, Rakshit A, Hussaindeen JR, Khadka J, Pesudovs K. Does non-strabismic amblyopia affect the quality of life of adults? Findings from a qualitative study. Ophthalmic Physiol Opt. 2021;41(5):996–1006. doi:10.1111/opo.12864.
  • Black AA, Wood JM, Hoang S, Thomas E, Webber AL. Impact of amblyopia on visual attention and visual search in children. Invest Ophthalmol Vis Sci. 2021;62(4):15–. doi:10.1167/iovs.62.4.15.
  • Birch EE, Kelly KR. Amblyopia and the whole child. Prog Retinal Eye Res. 2023;93:101168. doi:10.1016/j.preteyeres.2023.101168.
  • Harrington S, Davison PA, O’Dwyer V. School performance and undetected and untreated visual problems in schoolchildren in Ireland; a population-based cross-sectional study. Irish Educational Studies. 2021;41(2):1–22. doi:10.1080/03323315.2021.1899024.
  • Rosa H-A, Adrián A-C, Beatriz I-S, María-José L-C, Miguel-Ángel S. Psychomotor, psychosocial and reading skills in children with amblyopia and the effect of different treatments. J Mot Behav. 2020;53(2):1–9. doi:10.1080/00222895.2020.1747384.
  • Kelly KR, Morale SE, Beauchamp CL, Dao LM, Luu BA, Birch EE. Factors associated with impaired motor skills in strabismic and anisometropic children. Invest Ophthalmol Vis Sci. 2020;61(10):43–. doi:10.1167/iovs.61.10.43.
  • Horvat-Gitsels LA, Cortina-Borja M, Rahi JS, Khraisat OM. Educational attainment and trajectories at key stages of schooling for children with amblyopia compared to those without eye conditions: findings from the Millennium Cohort study. PLOS ONE. 2023;18(3):e0283786. doi:10.1371/journal.pone.0283786.
  • Steel DA, Codina CJ, Arblaster GE. Amblyopia treatment and quality of life: the child’s perspective on atropine versus patching. Strabismus. 2019;27(3):156–164. doi:10.1080/09273972.2019.1643894.
  • Birch EE, Castañeda YS, Cheng-Patel CS, et al. Self-perception of school-aged children with amblyopia and its association with reading speed and motor skills. JAMA Ophthalmol. 2019;137(2):167–174. doi:10.1001/jamaophthalmol.2018.5527.
  • Birch EE, Kelly KR, Giaschi DE. Fellow eye deficits in amblyopia. J Binocul Vis Ocul Motil. 2019;69(3):116–125. doi:10.1080/2576117X.2019.1624440.
  • Stewart CE, Wallace MP, Stephens DA, Fielder AR, Moseley MJ. The effect of amblyopia treatment on stereoacuity. J Aapos. 2013;17(2):166–173. doi:10.1016/j.jaapos.2012.10.021.
  • Webber AL, Wood JM, Thompson B. Fine motor skills of children with amblyopia improve following binocular TreatmentBinocular treatment improves fine motor skills. Invest Ophthalmol Vis Sci. 2016;57(11):4713–4720. doi:10.1167/iovs.16-19797.
  • Kelly KR, Jost RM, De La Cruz A, et al. Slow reading in children with anisometropic amblyopia is associated with fixation instability and increased saccades. J Aapos. 2017;21(6):447–451.e1. doi:10.1016/j.jaapos.2017.10.001.
  • Kelly KR, Jost RM, De La Cruz A, Birch EE. Amblyopic children read more slowly than controls under natural, binocular reading conditions. J Aapos. 2015;19(6):515–520. doi:10.1016/j.jaapos.2015.09.002.
  • Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121(11):1625–1632. doi:10.1001/archopht.121.11.1625.
  • Pediatric Eye Disease Investigator G. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years. Arch Ophthalmol. 2008;126(8):1039–1044. doi:10.1001/archopht.126.8.1039.
  • Dirani M, Shekar SN, Baird PN. The role of Educational attainment in refraction: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci. 2008;49(2):534–538. doi:10.1167/iovs.07-1123.